TP53 and neuroendocrine neoplasm: In addition, some of the cell lines used (BON, QGP1) have been characterized with regards to their genetic profile and have been shown to feature mutations untypical of neuroendocrine tumors or even neuroendocrine cancers (e.g. in TP53, TSC2) (48, 49).